ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,485Medicare Part D Prescriptions Filled, Including Refills

Rank: 203 out of 676

$422K Total Retail Price of All Prescriptions

Rank: 264 out of 676

361 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

29% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 9,184 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
FUROSEMIDE 367 306 1 4
HYDROCODONE-ACETAMINOPHEN 357 290 S3 2 1
LISINOPRIL 349 324 3 5
POTASSIUM CHLORIDE 309 274 4 9
OMEPRAZOLE 305 264 5 2
AMLODIPINE BESYLATE 293 268 6 3
LEVOTHYROXINE SODIUM 265 254 7 7
GABAPENTIN 238 189 8 10
METFORMIN HCL 220 205 9 8
WARFARIN SODIUM 189 186 10 18
SIMVASTATIN 188 175 11 6
CITALOPRAM HBR 181 177 12 17
PRAVASTATIN SODIUM 179 161 13 11
HYDROCHLOROTHIAZIDE 168 156 14 12
ZOLPIDEM TARTRATE 150 132 15 21
MELOXICAM 144 139 16 13
TRAMADOL HCL 138 117 17 19
METOPROLOL SUCCINATE 129 125 18 14
GLIMEPIRIDE 109 109 19 30
PREDNISONE 101 78 20 53
KLOR-CON 10 101 90 20 95
CARVEDILOL 100 92 22 15
DOXYCYCLINE HYCLATE 97 65 23 82
DONEPEZIL HCL 97 95 23 24
ATENOLOL 96 87 25 25
CLOPIDOGREL 92 79 26 28
ATORVASTATIN CALCIUM 92 91 26 20
METOPROLOL TARTRATE 83 68 28 22
BENAZEPRIL HCL 81 70 29 58
LEVOFLOXACIN 80 62 30 91
TRIAMTERENE-HCTZ 73 70 31 43
SPIRONOLACTONE 73 64 31 62
NEXIUM 73 60 31 23
ENALAPRIL MALEATE 70 59 34 65
DIOVAN 65 53 35 37
FLUTICASONE PROPIONATE 64 58 36 49
CLINDAMYCIN HCL 64 56 36 248
PLAVIX 63 47 38 40
CELEBREX 61 61 39 108
DIOVAN HCT 61 61 39 41
VENLAFAXINE HCL ER 61 60 39 98
EVISTA 60 60 42 119
INDOMETHACIN 60 52 R 42 240
CARBIDOPA-LEVODOPA 59 53 44 114
MECLIZINE HCL 58 55 45 83
CIPROFLOXACIN HCL 58 55 45 45
PRIMIDONE 56 52 47 312
AMLODIPINE BESYLATE-BENAZEPRIL 55 31 48 44
ATENOLOL-CHLORTHALIDONE 51 45 49 142
AMITRIPTYLINE HCL 51 41 R 49 46
NITROFURANTOIN MONO-MACRO 50 44 51 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.